Ignite Creation Date:
2024-05-05 @ 10:17 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005835
Status:
COMPLETED
Last Update Posted:
2023-04-10
First Post:
2000-06-02
Brief Title:
N99-02 Melphalan and Buthionine Sulfoximine
Sponsor:
New Approaches to Neuroblastoma Therapy Consortium
Organization:
New Approaches to Neuroblastoma Therapy Consortium
Organization Data
Organization:
New Approaches to Neuroblastoma Therapy Consortium
Class:
OTHER
Study ID:
CDR0000067849
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
New Approaches to Neuroblastoma Therapy Consortium
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |